Cargando…
The Universal Prescription for Parkinson’s Disease: Exercise
Over the past two decades, aerobic exercise has emerged as a mainstream recommendation to aid in treating Parkinson’s disease (PD). Despite the acknowledgement of the benefits of exercise for people with PD (PwPD), frequently, exercise recommendations lack specificity in terms of frequency, intensit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592674/ https://www.ncbi.nlm.nih.gov/pubmed/32925109 http://dx.doi.org/10.3233/JPD-202100 |
_version_ | 1783601233826676736 |
---|---|
author | Alberts, Jay L. Rosenfeldt, Anson B. |
author_facet | Alberts, Jay L. Rosenfeldt, Anson B. |
author_sort | Alberts, Jay L. |
collection | PubMed |
description | Over the past two decades, aerobic exercise has emerged as a mainstream recommendation to aid in treating Parkinson’s disease (PD). Despite the acknowledgement of the benefits of exercise for people with PD (PwPD), frequently, exercise recommendations lack specificity in terms of frequency, intensity and duration. Additionally, conflating physical activity with exercise has contributed to providing vague exercise recommendations to PwPD. Therefore, the beneficial effects of exercise may not be fully realized in PwPD. Data provided by animal studies and select human trials indicate aerobic exercise may facilitate structural and functional changes in the brain. Recently, several large human clinical trials have been completed and collectively support the use of aerobic exercise, specifically high-intensity aerobic exercise, in improving PD motor symptoms. Data from these and other studies provide the basis to include aerobic exercise as an integral component in treating PD. Based on positive clinical findings and trials, it is advised that PwPD perform aerobic exercise in the following dose: 3x/week, 30–40-minute main exercise set, 60–80% of heart rate reserve or 70–85% of heart rate max. In lieu of heart rate, individuals can achieve an intensity of 14–17 on a 20-point RPE scale. Ongoing clinical trials, SPARX3 and CYCLE-II, have potential to further develop patient-specific exercise recommendations through prognostic modeling. |
format | Online Article Text |
id | pubmed-7592674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-75926742020-10-30 The Universal Prescription for Parkinson’s Disease: Exercise Alberts, Jay L. Rosenfeldt, Anson B. J Parkinsons Dis Review Over the past two decades, aerobic exercise has emerged as a mainstream recommendation to aid in treating Parkinson’s disease (PD). Despite the acknowledgement of the benefits of exercise for people with PD (PwPD), frequently, exercise recommendations lack specificity in terms of frequency, intensity and duration. Additionally, conflating physical activity with exercise has contributed to providing vague exercise recommendations to PwPD. Therefore, the beneficial effects of exercise may not be fully realized in PwPD. Data provided by animal studies and select human trials indicate aerobic exercise may facilitate structural and functional changes in the brain. Recently, several large human clinical trials have been completed and collectively support the use of aerobic exercise, specifically high-intensity aerobic exercise, in improving PD motor symptoms. Data from these and other studies provide the basis to include aerobic exercise as an integral component in treating PD. Based on positive clinical findings and trials, it is advised that PwPD perform aerobic exercise in the following dose: 3x/week, 30–40-minute main exercise set, 60–80% of heart rate reserve or 70–85% of heart rate max. In lieu of heart rate, individuals can achieve an intensity of 14–17 on a 20-point RPE scale. Ongoing clinical trials, SPARX3 and CYCLE-II, have potential to further develop patient-specific exercise recommendations through prognostic modeling. IOS Press 2020-09-01 /pmc/articles/PMC7592674/ /pubmed/32925109 http://dx.doi.org/10.3233/JPD-202100 Text en © 2020 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Alberts, Jay L. Rosenfeldt, Anson B. The Universal Prescription for Parkinson’s Disease: Exercise |
title | The Universal Prescription for Parkinson’s Disease: Exercise |
title_full | The Universal Prescription for Parkinson’s Disease: Exercise |
title_fullStr | The Universal Prescription for Parkinson’s Disease: Exercise |
title_full_unstemmed | The Universal Prescription for Parkinson’s Disease: Exercise |
title_short | The Universal Prescription for Parkinson’s Disease: Exercise |
title_sort | universal prescription for parkinson’s disease: exercise |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592674/ https://www.ncbi.nlm.nih.gov/pubmed/32925109 http://dx.doi.org/10.3233/JPD-202100 |
work_keys_str_mv | AT albertsjayl theuniversalprescriptionforparkinsonsdiseaseexercise AT rosenfeldtansonb theuniversalprescriptionforparkinsonsdiseaseexercise AT albertsjayl universalprescriptionforparkinsonsdiseaseexercise AT rosenfeldtansonb universalprescriptionforparkinsonsdiseaseexercise |